Author

B. Gill‐Barman

Observed names: B Gill-Barman, B. Gill-Barman, Baljit Gill-Barman, Baljit Gill‐Barman

Institutions: Guy's Hospital, St Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust

Observed institutions: National Health Service, Guy's Hospital, St Thomas' Hospital, King's College London, Guy's and St Thomas' NHS Foundation Trust, Karolinska Institutet

OpenAlex ID: A5046046028

Lymph node regression and survival following neoadjuvant chemotherapy in oesophageal adenocarcinoma

2018 · A R Davies, D Myoteri, et al. · British journal of surgery · 63

Pathologic Lymph Node Regression After Neoadjuvant Chemotherapy Predicts Recurrence and Survival in Esophageal Adenocarcinoma: A Multicenter Study in the United Kingdom

2023 · Jonathan L. Moore, Michael Green, et al. · Journal of Clinical Oncology · 39

Effect of peri-operative chemotherapy regimen on survival in the treatment of locally advanced oesophago-gastric adenocarcinoma – A comparison of the FLOT and ‘MAGIC’ regimens

2022 · Jonathan L. Moore, Sacheen Kumar, et al. · European Journal of Cancer · 21

Diagnosis and subclassification of thymoma by minimally invasive fine needle aspiration directed by endobronchial ultrasound: a review and discussion of four cases

2012 · M. T. Moonim, R. Breen, et al. · Cytopathology · 20

Impact of incremental circumferential resection margin distance on overall survival and recurrence in oesophageal adenocarcinoma

2018 · W. R. C. Knight, J. Zylstra, et al. · BJS Open · 16

PDF

Initial experience in staging primary oesophageal/gastro-oesophageal cancer with 18F-FDG PET/MRI

2021 · Amy R. Sharkey, Bert-Ram Sah, et al. · European Journal of Hybrid Imaging · 12

PDF

Metabolic tumour and nodal response to neoadjuvant chemotherapy on FDG PET-CT as a predictor of pathological response and survival in patients with oesophageal adenocarcinoma

2023 · Jonathan L. Moore, Manil Subesinghe, et al. · European Radiology · 11

PDF

Clinical Relevance of the Tumor Location-Modified Laurén Classification System for Gastric Cancer in a Western Population

2022 · J. L. Moore, A. R. Davies, et al. · Annals of Surgical Oncology · 7

PDF

Does a high Mandard score really define a poor response to chemotherapy in oesophageal adenocarcinoma?

2021 · William R. C. Knight, Cara R. Baker, et al. · British Journal of Cancer · 7

Prediction of a positive circumferential resection margin at surgery following neoadjuvant chemotherapy for adenocarcinoma of the oesophagus

2019 · W. R. C. Knight, C. Yip, et al. · BJS Open · 5

PDF

Comparing the utility of FDG PET-CT and contrast-enhanced CT in patients with oesophagogastric adenocarcinoma treated with neoadjuvant chemotherapy

2026 · J. L. Moore, M. Arora, et al. · European Radiology

PDF

P245 Old story, new angle. In-situ demonstration of mycobacterium paratuberculosis in lamina propria immune cells using IS900 FISH in crohn’s disease

2026 · Marcus Barr, Neil Rayment, et al. · Gut

Incidental appendicectomy in pancreas transplantation: A single‐center study

2023 · Aliyah Hussein, Nikolaos Karydis, et al. · Clinical Transplantation

PDF

O046 Incidental appendicectomy in pancreas transplantation: a single-centre study

2022 · A Hussein, B Gill-Barman, et al. · British journal of surgery

PDF

ASO Visual Abstract: Clinical Relevance of the Tumor Location-Modified Laurén Classification System of Gastric Cancer in a Western Population

2022 · Jonathan L. Moore, Andrew R. Davies, et al. · Annals of Surgical Oncology

PDF

P-198 The role of active surveillance for Bethesda III/IV thyroid nodules and the differential risk associated with nuclear atypia in Bethesda III category cytology

2021 · Jennifer Collins, Arunjit Takhar, et al. · Oral Oncology

Works count: 16

Citation count: 201

H-index: 7

I10-index: 7